Exploring the interplay between metabolic dysfunction-associated fatty liver disease and gut dysbiosis: Pathophysiology, clinical implications, and emerging therapies

Table 1 Key microbial biomarkers and diagnostic performance in metabolic dysfunction-associated fatty liver disease

Microbial biomarker	Diagnostic performance (AUC)	Ref.
Desulfobacteraceae	0.84	Mascardi et al[120]
Mushu phage	0.83	Mascardi et al[120]
Butyric acid	0.83	Yang et al[122]
Acetic acid	0.70	Yang et al[122]
Machine learning model	0.93-0.96	Park et al[125]; Kang et al[31]

AUC: Area under the curve.